Economic Assessment

Health economic evaluation is a decision-making tool that helps document the full range of economic, medical, and organizational impacts of innovative health technologies.

Its purpose is to identify which ones yield the best returns for every unit of currency invested.

As a complement to clinical evaluation, economic evaluation has, over the past few decades, become a key criterion in the analysis of innovative health technologies.

Economic evaluation is a methodological and statistical discipline in its own right. It draws on a variety of approaches and sources of information and requires specific expertise and skills.

We are committed to addressing our clients’ questions and meeting their needs regarding economic evaluation, particularly with regard to the requirements set by health authorities for market access.

Through this division, MedConsult supports companies in the medical device and pharmaceutical sectors with their healthcare initiatives.

Public agencies, mutual insurance companies, and insurers: our services can also meet your needs and expectations regarding economic analysis. Please feel free to contact us.

Our team is highly skilled in economic evaluation methods in healthcare:

efficiency analyses,
budget impact analyses,
identification and assessment of treatment costs and care pathways,
identification of relevant data sources
and the application of statistical analysis.

She also has extensive expertise in:

the terms and conditions for accessing the French market,
the expectations of health authorities,
the regulatory and methodological aspects of clinical research
as well as on the hospital setting in which technological innovations are introduced.

Since November 2022, Nathalie Préaubert, our Head of Health Economic Evaluation, has been listed by Bpifrance as an expert in the design and drafting of health economic evaluation protocols for market access, as part of the “Diagnostic DM” component of the France 2030 plan.